LIFE TECHNOLOGIES CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2010-12-14: Form 8-K; Period of report 2010-12-09; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Details 1.01.
- 2010-12-02: Form 8-K; Period of report 2010-11-29; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2010-10-26: Form 8-K; Period of report 2010-10-26; Description 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; Details 2.02.
- 2010-10-18: Form 8-K; Period of report 2010-10-15; Description 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Details 5.03.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2010-12-14 | 8-K | 2010-12-09 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 On December 9, 2010, Life Technologies Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with the several underwriters named therein, for whom Merrill Lynch, Pierce, Fenner & Smith Incorporated and RBS Securities Inc. have acted as the representatives, for the issuance and sale by the Company of $400 million aggregate principal amount of its 3.50% Senior Notes due 2016 (the “2016 Notes”) and $400 million aggregate principal amount of its 5.00% Senior Notes due 2021 (the “2021 Notes” and together with the 2016 Notes, the “Notes”). 2.03 (a) The information provided under Item 1.01 of this Form 8-K is incorporated into this Item 2.03(a) by reference. | a58129e8vk.htm |
| 2010-12-02 | 8-K | 2010-11-29 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On November 29, 2010, the Company determined and internally announced that, effective January 1, 2011, Mr. Bernd Brust will transition from his current role as the Company’s President, Commercial Operations, to the role of President, Molecular Medicine. | a58000e8vk.htm |
| 2010-10-26 | 8-K | 2010-10-26 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 On October 26, 2010, Life Technologies Corporation, or the Company, issued a press release regarding the Company’s financial results for the period ended September 30, 2010. 7.01 See the information set forth under Item 2.02 above and attached as Exhibit 99.1 hereto. | a57644e8vk.htm |
| 2010-10-18 | 8-K | 2010-10-15 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 On October 15, 2010, the Company’s Board of Directors approved certain changes to the Company’s Bylaws in the form of the Company’s Sixth Amended and Restated Bylaws. | a57592e8vk.htm |
| 2010-08-17 | 8-K | 2010-08-17 | 8.01 Other Events | 8.01 On August 17, 2010, Life Technologies Corporation, a Delaware corporation (the “Company”) issued a press release with respect to the execution of a definitive agreement to acquire Ion Torrent Systems Incorporated, a Delaware corporation (“Ion”) for $375 million in cash and stock. | a57106e8vk.htm |
| 2010-07-29 | 8-K | 2010-07-27 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 8.01 Other Events | 2.02 On July 29, 2010, Life Technologies Corporation, or the Company, issued a press release regarding the Company’s financial results for the period ended June 30, 2010. 7.01 See the information set forth under Item 2.02 above and attached as Exhibit 99.1 hereto. 8.01 The Company’s press release issued on July 29, 2010, included the announcement of a stock repurchase program. | a56839e8vk.htm |
| 2010-07-07 | 8-K | 2010-07-06 | 8.01 Other Events | 8.01 On July 6, 2010, the Company notified the holders of the Company’s 2.0% Convertible Senior Notes, Due 2023 of their right, pursuant to the applicable indenture, to cause the Company to repurchase their notes on July 30, 2010. | a56646e8vk.htm |
| 2010-07-07 | 8-K | 2010-07-07 | 8.01 Other Events | 8.01 On July 7, 2010, Life Technologies Corporation (the “Company”) sent notice to holders of the Company’s 2.0% Convertible Senior Notes, Due 2023 (the “Notes”) that the Company will optionally redeem all of the outstanding Notes on August 6, 2010 pursuant to Section 3.1 of the Indentures, dated August 1, 2003 and December 14, 2004, between Life Technologies Corporation (formerly known as Invitrogen Corporation) and U.S. Bank National Association. | a56645e8vk.htm |
| 2010-06-30 | 8-K | 2010-06-30 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On June 30, 2010, William S. Shanahan submitted a retirement letter announcing his retirement from the Board of Directors of Life Technologies Corporation (“Company”) to pursue other matters. | a56618e8vk.htm |
| 2010-06-01 | 8-K | 2010-05-28 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. | a56340e8vk.htm |
| 2010-05-03 | 8-K | 2010-04-28 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders | 5.02 On April 29, 2010, at the Annual Meeting of Stockholders (Annual Meeting) of Life Technologies Corporation (Company), the Company’s stockholders approved and adopted the 2010 Incentive Compensation Plan (Plan). 5.03 The information set forth in Item 5.07 of this Report regarding the amendment of the Restated Certificate of Incorporation of the Company (Certificate) to adopt a majority voting standard for uncontested director elections and to eliminate supermajority voting requirements is incorporated herein by reference. 5.07 (a) On April 29, 2010, the Company held its Annual Meeting. | a55993e8vk.htm |
| 2010-04-27 | 8-K | 2010-04-27 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 7.01 On April 27, 2010, Life Technologies Corporation, or the Company, issued a press release regarding the Company’s financial results for the period ended March 31, 2010. | a55909e8vk.htm |
| 2010-02-19 | 8-K | 2010-02-19 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 On February 19, 2010, Life Technologies Corporation (the “Company”) issued and sold $250 million aggregate principal amount of its 3.375% Senior Notes due 2013 (the “2013 Notes”), $500 million aggregate principal amount of its 4.400% Senior Notes due 2015 (the “2015 Notes”) and $750 million aggregate principal amount of its 6.000% Senior Notes due 2020 (the “2020 Notes” and together with the 2013 Notes and 2015 Notes, the “Notes”). 2.03 (a) The information provided under Item 1.01 of this Form 8-K is incorporated into this Item 2.03(a) by reference. | a55265e8vk.htm |
| 2010-02-17 | 8-K | 2010-02-11 | 1.01 Entry into a Material Definitive Agreement | 1.01 On February 11, 2010, Life Technologies Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with the several underwriters named therein, for whom Banc of America Securities LLC, Goldman, Sachs & Co. and J.P Morgan Securities Inc. will act as the representatives, for the issuance and sale by the Company of $250 million aggregate principal amount of its 3.375% Senior Notes due 2013 (the “2013 Notes”), $500 million aggregate principal amount of its 4.400% Senior Notes due 2015 (the “2015 Notes”) and $750 million aggregate principal amount of its 6.000% Senior Notes due 2020 (the “2020 Notes” and together with the 2013 Notes and 2015 Notes, the “Notes”). | a55219e8vk.htm |
| 2010-02-10 | 8-K/A | 2010-01-28 | 2.02 Results of Operations and Financial Condition | 2.02 On January 28, 2010, the Company issued a press release regarding the Company’s financial results for the period ended December 31, 2009 and filed a Form 8-K furnishing the press release. | a55110e8vkza.htm |
| 2010-02-05 | 8-K/A | 2008-11-21 | 9.01 Financial Statements and Exhibits | a55057e8vkza.htm | |
| 2010-01-29 | 8-K | 2010-01-29 | 8.01 Other Events | 8.01 Unless otherwise specific or the context otherwise indicates, all references to the words “The Company”, “we” or “Life Technologies” refer to Life Technologies Corporation and all entities included in our consolidated financial statements. | a54968e8vk.htm |
| 2010-01-28 | 8-K | 2010-01-28 | 8.01 Other Events | 8.01 On January 28, 2010 at 8:30 a.m. | a54978e8vk.htm |
| 2010-01-28 | 8-K | 2010-01-28 | 2.02 Results of Operations and Financial Condition | 2.02 On January 28, 2010, the Company issued a press release regarding the Company’s financial results for the period ended December 31, 2009. | a54957e8vk.htm |
| 2010-01-27 | 8-K | 2010-01-27 | 8.01 Other Events | 8.01 On January 27, 2010, Life Technologies Corporation (the “Company”) requested a waiver from the lenders under its existing credit agreement, dated November 21, 2008, among Life Technologies, the lenders party thereto, Bank of America, N.A. as administrative agent, UBS Securities LLC and Morgan Stanley Senior Funding, Inc. as co-syndication agents, and DnB Nor Bank, ASA and The Bank of Nova Scotia as co-documentation agents (the “Credit Agreement”). | a54951e8vk.htm |
| 2010-01-22 | 8-K | 2010-01-22 | 8.01 Other Events | 8.01 “Pursuant to Section 4.1 of the Indentures, dated August 1, 2003 and December 14, 2004, between Life Technologies Corporation (formerly known as Invitrogen Corporation) and U.S. Bank National Association, Life Technologies Corporation is providing public notice to the holders of the above referenced notes that they have the right to convert the notes. | a54927e8vk.htm |